Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in ...

New study shows that cancer damages its own DNA by pushing key genes to work too hard. Researchers found that the most ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread.

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...

New research reveals that certain brain tumors may originate silently within normal brain cells long before a tumor forms.

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy found that ...

A study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene ...

Europe is preparing to take cancer research beyond Earth. At Frontiers Science House in ...